Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Lifecare AS ( (DE:LFC0) ) has issued an announcement.
Lifecare ASA has announced that Chief Financial Officer Renete Kaarvik will leave the company to take up a position elsewhere, but will remain in her role during a transition period, including through the ongoing rights issue, to safeguard the company’s financial routines and ensure an orderly handover. The company emphasized that Kaarvik’s new role creates no conflict of interest and that arrangements are being put in place to secure continuity in the CFO function, a key consideration for investors and other stakeholders during a capital-raising phase and as Lifecare advances its medical sensor and continuous glucose monitoring ambitions.
More about Lifecare AS
Lifecare ASA is a medical sensor company specializing in technology for sensing and monitoring various body analytes, with a primary focus on developing next-generation continuous glucose monitoring (CGM) systems. Using osmotic pressure as its sensing principle, the company aims to offer advanced monitoring solutions for a wide range of molecules in humans and pets, positioning itself within the growing market for innovative biosensor and diabetes management technologies.
YTD Price Performance: -46.47%
Average Trading Volume: 128,280
Current Market Cap: NOK33.26M
Find detailed analytics on LFC0 stock on TipRanks’ Stock Analysis page.